check_circleStudy Completed
Contraception
Bayer Identifier:
91555
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles
Trial purpose
This study is examining a birth control patch for 13 cycles (1 year).
Key Participants Requirements
Sex
FemaleAge
18 - 45 YearsTrial summary
Enrollment Goal
1502Trial Dates
May 2009 - December 2010Phase
Phase 3Could I Receive a placebo
NoProducts
Gestodene/EE Patch (BAY86-5016)Accepts Healthy Volunteer
YesWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Chattanooga, 37404, United States | |
Completed | Philadelphia, 19114, United States | |
Completed | Precision Trials | Phoenix, 85032, United States |
Completed | Rosemark Women Care Specialist | Idaho Falls, 83404, United States |
Completed | Visions Clinical Research | Boynton Beach, 33472-2952, United States |
Completed | South Bend, 46601, United States | |
Completed | Boston, 02118, United States | |
Completed | Genesis Center for Clinical Research | San Diego, 92103, United States |
Completed | Corpus Christi, 78414, United States | |
Completed | Winston-Salem, 27103, United States | |
Completed | San Diego, 92108, United States | |
Completed | Albuquerque, 87102, United States | |
Completed | Miami, 33186, United States | |
Completed | Visions Clinical Research - Tucson | Tucson, 85712, United States |
Completed | Portland, 97239-3011, United States | |
Completed | Jacksonville, 32207, United States | |
Completed | Mt. Pleasant, 29464, United States | |
Completed | Decatur, 30034, United States | |
Completed | New Bern, 28562, United States | |
Completed | Columbus, 43213, United States | |
Completed | San Diego, 92123, United States | |
Completed | Newburgh, 47630, United States | |
Completed | Moorestown, 08057, United States | |
Completed | Office of Dr. R. Garn Mabey, MD | Las Vegas, 89128, United States |
Completed | Chaska, 55318, United States | |
Completed | Marrero, 70072, United States | |
Completed | Columbia, 29201, United States | |
Completed | Las Vegas, 89106, United States | |
Completed | Glendale, 85304, United States | |
Completed | Roswell, 30075, United States | |
Completed | Winston-Salem, 27103, United States | |
Completed | Denver, 80218, United States | |
Completed | New York, 10032, United States | |
Completed | Women's Care Center, PLC | Memphis, 38119, United States |
Completed | Lincoln, 68510, United States | |
Completed | Research Associates | Boise, 83702, United States |
Completed | Carmichael, 95608, United States | |
Completed | Knoxville, 37920, United States | |
Completed | Las Vegas, 89030, United States | |
Completed | Women's Clinical Research Center | Seattle, 98105, United States |
Completed | Torrance, 90502, United States | |
Completed | Chicago, 60612, United States | |
Completed | Pacific Palisades, 90272, United States | |
Completed | Lawrenceville, 08648, United States | |
Completed | Paramount, 90723, United States | |
Completed | Littleton, 80122, United States | |
Completed | Cleveland, 44122, United States | |
Completed | Warwick, 02886, United States | |
Completed | Nashville, 37203, United States | |
Completed | Birmingham, 35235, United States | |
Completed | Meridien Research | St. Petersburg, 33709, United States |
Completed | Pittsburgh, 15213, United States | |
Completed | Atlanta, 30328, United States | |
Completed | Eugene, 97401, United States | |
Completed | The Woman's Hospital of Texas | Houston, 77054, United States |
Completed | Cincinnati, 45267-0457, United States | |
Completed | Norfolk, 23507, United States | |
Completed | Nashville, 37205, United States | |
Completed | Advances in Health, inc. | Houston, 77030, United States |
Completed | Pembroke Pines, 33024, United States | |
Completed | Santa Ana, 92705, United States | |
Completed | New London, 06320, United States | |
Completed | Practice Research Organization | Dallas, 75230, United States |
Completed | York Clinical Consulting | Oklahoma City, 73120, United States |
Primary Outcome
- Occurrence of pregnancy (yes/no) while on treatmentdate_rangeTime Frame:13 treatment cycles each consisting of 28 days and follow-up period of 14 daysenhanced_encryptionnoSafety Issue:
Secondary Outcome
- Vital signsdate_rangeTime Frame:13 treatment cycles each consisting of 28 daysenhanced_encryptionyesSafety Issue:
- Physical and gynecological examinationsdate_rangeTime Frame:13 treatment cycles each consisting of 28 daysenhanced_encryptionyesSafety Issue:
- Laboratory assessmentsdate_rangeTime Frame:13 treatment cycles each consisting of 28 daysenhanced_encryptionyesSafety Issue:
- Adverse events (AE monitoring)date_rangeTime Frame:13 treatment cycles each consisting of 28 daysenhanced_encryptionyesSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
PreventionAllocation
Non-randomizedBlinding
Open LabelAssignment
Single Group AssignmentTrial Arms
1